2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase 1
1
Status
Recruiting
3
Withdrawn
1
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Genitourinary
4
Conditions
Prostatic Neoplasms
121
Neoplasm Metastasis
12
Prostate Cancer Metastatic
4
Oligometastatic Prostate Cancer
3
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
3
Metastatic Hormone-sensitive Prostate Cancer
3
Adenocarcinoma
3
Radiation Injuries
2
Prostatic Diseases
2
Prostate CA
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms
2
Metastatic Castration-resistant Prostate Cancer
2
Urologic Diseases
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage IV Prostate Adenocarcinoma AJCC v7
1
Stage I Prostate Adenocarcinoma
1
Salivary Gland Neoplasms
1
Recurrence
1
Prostatic Neoplasms, Castration-Resistant
1
Prostate Adenocarcinoma
1
PSA Level Greater Than 0.03
1
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
1
Non-metastatic, Hormone naïve Prostate Cancer
1
Neoplasm Recurrence, Local
1
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1
Metastatic Hormone-Sensitive Prostate Cance
1
Metastatic Hormone Sensitive Prostate Cancer
1
Metastatic Castration-sensitive Prostate Cancer
1
Interventions
enzalutamide
7
Prednisone
7
cabazitaxel
6
Radiosurgery
6
Docetaxel
5
Androgen Antagonists
4
Abiraterone Acetate
4
XRP6258
2
Standard of Care
2
talazoparib
1
sipuleucel-T
1
rucaparib
1
pembrolizumab
1
olaparib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
darolutamide
1
apalutamide
1
Zuclomiphene
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Prednisolone
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Midazolam
1
Lutetium-177
1
Lutetium
1
Lenograstim
1
LY3023414
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Prostate Cancer Metastatic
×
Androgen Antagonists
×
Clear all
NCT04916613
2026-04-28
GETUG-AFU 40
UNICANCER
Phase 3
Recruiting
300 enrolled
NCT04983095
2026-02-17
METRO
Umeå University
Phase NA
Recruiting
118 enrolled
NCT06320067
2025-09-26
STAMPEDE2
University College, London
Phase 3
Recruiting
3,360 enrolled
NCT05567770
2023-08-24
ACTION
Weill Medical College of Cornell University
Phase 1
Withdrawn